Targacept, Inc. Appoints John P. Richard As Chairman Of The Board Of Directors
Published: Jan 08, 2014
Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced that John P. Richard, a Targacept non-executive director since November 2002, has been appointed as the Company’s Chairman of the Board effective January 1, 2014. Mr. Richard will continue to serve on the Company’s audit and compensation committees.
Help employers find you! Check out all the jobs and post your resume.